28,656 Shares in HCA Healthcare, Inc. $HCA Purchased by SCS Capital Management LLC

Key Points

• SCS Capital Management LLC invested approximately $9.90 million in HCA Healthcare, acquiring 28,656 shares of the company's stock.
• In Q1, several institutional investors significantly increased their stakes in HCA, including GAMMA Investing LLC, which raised its position by a staggering 40,527.3%.
• HCA Healthcare recently announced a quarterly dividend of $0.72 per share, with an annualized yield of 0.7%, and its payout ratio currently sits at 12.11%.

SCS Capital Management LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 28,656 shares of the company's stock, valued at approximately $9,902,000.

A number of other institutional investors also recently made changes to their positions in HCA. Price T Rowe Associates Inc. MD increased its holdings in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Nuveen Asset Management LLC lifted its stake in HCA Healthcare by 4.5% during the fourth quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock worth $560,011,000 after purchasing an additional 81,105 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock worth $615,583,000 after purchasing an additional 587,036 shares during the last quarter. GAMMA Investing LLC lifted its stake in HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in HCA Healthcare by 12.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,675,460 shares of the company's stock worth $502,889,000 after purchasing an additional 188,093 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently commented on HCA shares. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Barclays lowered their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Morgan Stanley lowered their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $403.17.

HCA Healthcare Stock Performance

Shares of NYSE:HCA traded up $2.69 on Friday, hitting $405.54. The company's stock had a trading volume of 761,184 shares, compared to its average volume of 1,129,364. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $420.98. The company has a market capitalization of $94.89 billion, a price-to-earnings ratio of 17.05, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. The stock's 50-day moving average is $382.88 and its two-hundred day moving average is $362.77. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.